5,738 reports of this reaction
5.7% of all MIRABEGRON reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for MIRABEGRON, manufactured by Astellas Pharma US, Inc.. There are 5,738 FDA adverse event reports linking MIRABEGRON to DRUG INEFFECTIVE. This represents approximately 5.7% of all 99,871 adverse event reports for this drug.
MIRABEGRON has an overall safety score of 78 out of 100. Patients taking MIRABEGRON who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among MIRABEGRON users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for MIRABEGRON:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 5,738 FDA reports for MIRABEGRON. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 5.7% of all adverse event reports for MIRABEGRON, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking MIRABEGRON, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.